1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South and Central America Embolization Agents Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South and Central America Embolization Agents Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South and Central America Embolization Agents Market Regional Analysis
6.2 South and Central America Embolization Agents Market Revenue 2019-2028 (US$ Million)
6.3 South and Central America Embolization Agents Market Forecast Analysis
7. South and Central America Embolization Agents Market Analysis – by Product
7.1 Coils
- 7.1.1 Overview
- 7.1.2 Coils: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Plugs
- 7.2.1 Overview
- 7.2.2 Plugs: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Beads/Particles
- 7.3.1 Overview
- 7.3.2 Beads/Particles: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Detachable Balloons
- 7.4.1 Overview
- 7.4.2 Detachable Balloons: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Glue
- 7.5.1 Overview
- 7.5.2 Glue: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.6 Sponge
- 7.6.1 Overview
- 7.6.2 Sponge: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.7 Liquid Embolics
- 7.7.1 Overview
- 7.7.2 Liquid Embolics: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.8 Sclerosants
- 7.8.1 Overview
- 7.8.2 Sclerosants: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.9 Precipitating Agents
- 7.9.1 Overview
- 7.9.2 Precipitating Agents: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. South and Central America Embolization Agents Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Neurology
- 8.2.1 Overview
- 8.2.2 Neurology: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Urology
- 8.3.1 Overview
- 8.3.2 Urology: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Cardiology
- 8.4.1 Overview
- 8.4.2 Cardiology: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Peripheral Vascular Diseases
- 8.5.1 Overview
- 8.5.2 Peripheral Vascular Diseases: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. South and Central America Embolization Agents Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Cardiac Centers
- 9.2.1 Overview
- 9.2.2 Cardiac Centers: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: South and Central America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. South and Central America Embolization Agents Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America
- 10.2.1 South and Central America Embolization Agents Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 South and Central America Embolization Agents Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 Brazil: South and Central America Embolization Agents Market Breakdown, by Product
- 10.2.1.1.2 Brazil: South and Central America Embolization Agents Market Breakdown, by Application
- 10.2.1.1.3 Brazil: South and Central America Embolization Agents Market Breakdown, by End User
- 10.2.1.2 Argentina:
South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Argentina: South and Central America Embolization Agents Market Breakdown, by Product
- 10.2.1.2.2 Argentina: South and Central America Embolization Agents Market Breakdown, by Application
- 10.2.1.2.3 Argentina: South and Central America Embolization Agents Market Breakdown, by End User
- 10.2.1.3 Rest of South and Central America :
South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Rest of South and Central America : South and Central America Embolization Agents Market Breakdown, by Product
- 10.2.1.3.2 Rest of South and Central America : South and Central America Embolization Agents Market Breakdown, by Application
- 10.2.1.3.3 Rest of South and Central America : South and Central America Embolization Agents Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Boston Scientific Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cook Medical LLC
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 DePuy Synthes
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 KANEKA CORPORATION
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtronic
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merit Medical Systems Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Stryker Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Terumo Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations